Dual-color silver-enhanced in situ hybridization for assessing HER2 gene amplification in breast cancer
- PMID: 21317877
- DOI: 10.1038/modpathol.2011.9
Dual-color silver-enhanced in situ hybridization for assessing HER2 gene amplification in breast cancer
Abstract
Amplification of the human epidermal growth factor receptor 2 (HER2) gene occurs in 20-25% of breast cancers, and is recognized as a prognostic and predictive marker. HER2 gene amplification, evaluated as a change in protein expression or gene copy number, can be identified by a number of methods. Fluorescence in situ hybridization (FISH) is considered the gold standard for HER2 gene copy number determination; however, a number of impediments prevent its wider use in a clinical setting. The aims of our study were to compare dual-color silver-enhanced in situ hybridization (SISH) with single-color SISH and FISH on formalin-fixed, paraffin-embedded sections, and to validate its use as a routine method for assessing HER2 status in breast cancers. A total of 146 invasive breast carcinoma cases were assessed for HER2 gene amplification by FISH and dual-color SISH. Dual-color SISH and FISH results exhibited a concordance rate of 97% (κ=0.912). A comparison of the single-color SISH method with dual-color SISH showed that 142 of 146 cases were in agreement (97%, κ=0.930). Our results showed that dual-color SISH is a viable alternative to FISH that offers a number of advantages in a clinical setting.
Similar articles
-
Determination of HER2 gene amplification in breast cancer using dual-color silver enhanced in situ hybridization (dc- SISH) and comparison with fluorescence ISH (FISH).Asian Pac J Cancer Prev. 2013;14(10):6131-4. doi: 10.7314/apjcp.2013.14.10.6131. Asian Pac J Cancer Prev. 2013. PMID: 24289638
-
Bright-field in situ hybridization for HER2 gene amplification in breast cancer using tissue microarrays: correlation between chromogenic (CISH) and automated silver-enhanced (SISH) methods with patient outcome.Diagn Mol Pathol. 2009 Jun;18(2):88-95. doi: 10.1097/PDM.0b013e31816f6374. Diagn Mol Pathol. 2009. PMID: 19430296
-
Silver in situ hybridization (SISH) for determination of HER2 gene status in breast carcinoma: comparison with FISH and assessment of interobserver reproducibility.Am J Surg Pathol. 2010 Jun;34(6):767-76. doi: 10.1097/PAS.0b013e3181d96231. Am J Surg Pathol. 2010. PMID: 20421783
-
Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas.Braz J Med Biol Res. 2013 Mar;46(3):207-16. doi: 10.1590/1414-431x20132483. Epub 2013 Mar 19. Braz J Med Biol Res. 2013. PMID: 23558859 Free PMC article. Review.
-
[HER-2 oncogene amplification assessment in invasive breast cancer by dual-color in situ hybridization (dc-CISH): a comparative study with fluorescent in situ hybridization (FISH)].Ann Pathol. 2011 Dec;31(6):472-9. doi: 10.1016/j.annpat.2011.10.013. Epub 2011 Nov 26. Ann Pathol. 2011. PMID: 22172120 Review. French.
Cited by
-
Predicting breast cancer types on and beyond molecular level in a multi-modal fashion.NPJ Breast Cancer. 2023 Mar 22;9(1):16. doi: 10.1038/s41523-023-00517-2. NPJ Breast Cancer. 2023. PMID: 36949047 Free PMC article.
-
A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer.Nat Commun. 2022 Oct 12;13(1):6002. doi: 10.1038/s41467-022-33267-z. Nat Commun. 2022. PMID: 36224176 Free PMC article. Clinical Trial.
-
HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation.J Pathol Transl Med. 2020 Jan;54(1):34-44. doi: 10.4132/jptm.2019.11.03. Epub 2019 Nov 6. J Pathol Transl Med. 2020. PMID: 31693827 Free PMC article. Review.
-
What to expect from the 2018 ASCO/CAP HER2 guideline in the reflex in situ hybridization test of immunohistochemically equivocal 2+ cases?Virchows Arch. 2019 Sep;475(3):303-311. doi: 10.1007/s00428-019-02567-z. Epub 2019 Apr 5. Virchows Arch. 2019. PMID: 30953146
-
HER2 testing in gastric cancer: An update.World J Gastroenterol. 2016 May 21;22(19):4619-25. doi: 10.3748/wjg.v22.i19.4619. World J Gastroenterol. 2016. PMID: 27217694 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous